Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Baricitinib is effective as a treatment for severe hair loss.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Peps help Arabidopsis plants grow more root hairs by affecting specific genes and calcium signaling.

Apremilast did not work for treating severe alopecia areata.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Total glucosides of paeony may help treat alopecia areata by reducing inflammation and hair loss.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

PP405 shows promise as a new, effective treatment for hair loss with minimal side effects.

A substance called 15-deoxy prostaglandin J2 can cause hair follicle cells to die, which might explain how prostaglandin D2 can lead to hair loss.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Kojyl cinnamate ester derivatives can promote hair growth by increasing adiponectin production in fat tissues.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Thymosin β4 helps with healing, inflammation, and organ protection.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Growth hormone therapy can improve symptoms and growth in children with Vitamin-D Dependent Rickets Type-2.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Glycyrrhizic acid may help reduce unwanted hair growth.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Palmitoyl tetrapeptide-20 may help reduce hair greying and increase melanin production.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.